The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Progression-free survival as a surrogate endpoint of overall survival in advanced biliary tract cancer: A meta-analysis of randomized trials and individual-patient level correlation.
 
Carles Fabregat Franco
Travel, Accommodations, Expenses - Eisai Europe; Incyte Japan
 
Florian Castet
No Relationships to Disclose
 
Adelaida La Casta
Travel, Accommodations, Expenses - Roche
 
Jorge Adeva
No Relationships to Disclose
 
Alfredo Castillo
No Relationships to Disclose
 
Andrés Muñoz
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb/Pfizer; Celgene; Daiichi Sankyo; Incyte; LEO Pharma; Lilly; MSD Oncology; Roche; Sanofi; SERVIER
Speakers' Bureau - Bayer; Menarini; Rovi; SERVIER; STADA
Research Funding - Celgene; LEO Pharma; Rovi; Sanofi
Patents, Royalties, Other Intellectual Property - Risk assessment model in venous thromboembolism in cancer patients
Travel, Accommodations, Expenses - Amgen; Celgene; Merck Serono; Pfizer; Roche; SERVIER
 
Paloma Peinado
No Relationships to Disclose
 
Eva Martínez de Castro
No Relationships to Disclose
 
Miriam Lobo
Honoraria - LEO Pharma; Pfizer; SERVIER; Vifor Pharma
Consulting or Advisory Role - Fresenius Kabi
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; Novartis; SERVIER
 
Monica Granja
Honoraria - Lilly O.; Merck; SERVIER
Consulting or Advisory Role - SERVIER
Travel, Accommodations, Expenses - SERVIER
 
Rosa Maria Rodriguez-Alonso
Speakers' Bureau - Merck
Expert Testimony - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck
 
Ana Fernandez Montes
Consulting or Advisory Role - Amgen; Sanofi
Speakers' Bureau - Amgen; AstraZeneca; Celgene; Lilly; Lilly; Roche; Sanofi; seagen; SERVIER
 
Ruth Vera
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Lilly O.; Merck; Merck; MSD; Roche
Speakers' Bureau - Amgen; Lilly O.; Merck; Merck; MSD; Roche
 
Javier Gallego
No Relationships to Disclose
 
Begoña Graña
No Relationships to Disclose
 
Ismael Ghanem
No Relationships to Disclose
 
Inmaculada Alés
Consulting or Advisory Role - Esteve; Lilly O.; Merck
 
Raquel Molina
No Relationships to Disclose
 
Teresa Macarulla
Consulting or Advisory Role - Ability Pharma; Advance Medical; Amgen; Aptitude Health; AstraZeneca; Basilea; Baxter; BioLineRX; Celgene; Eisai; Ellipses Pharma; Esteve; Incyte; Ipsen; Janssen; Lilly; Medscape; MFAR, Marketing Farmacéutico & Investigación Clínica; MSD; Novocure; Paraxel; Prime Oncology; QED Therapeutics; Roche; Sanofi/Aventis; SERVIER; Zymeworks
Research Funding - Abbvie (Inst); Ability Pharma (Inst); Agios (Inst); Amc Medical Research (Inst); Amgen (Inst); Armo Biosciences (Inst); ASLAN Pharmaceuticals (Inst); ASTRAZENECA (Inst); Basilea Pharmaceutical (Inst); Bayer (Inst); Beigene (Inst); BiolineRx (Inst); Blueprint Medicines (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (BMS) (Inst); Cantargia AB (Inst); Celgene (Inst); Eisai (Inst); ERYTECH Pharma (Inst); Fibrogen (Inst); Genentech (Inst); Halozyme (Inst); Immunomedics (Inst); Incyte (Inst); Ipsen (Inst); Keralty Group (Inst); Lilly (Inst); Loxo (Inst); Medimmune (Inst); Merck Sharp & Dohme (Inst); Merrimack (Inst); Millennium (Inst); Nelum Corp. (Inst); Novartis (Inst); Novocure (Inst); OncoMed (Inst); Pfizer (Inst); Pharmacyclics (Inst); Roche (Inst); Roche (Inst); VCN Biosciences (Inst); Zymeworks (Inst)
Travel, Accommodations, Expenses - Celgene; H3 Biomedicine; Incyte; Merck; Prime Oncology; Sanofi; SERVIER
 
Enrique Aranda
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Merck; Roche; Sanofi; SERVIER
Research Funding - Roche